Insider filing · XENE
Sherry Aulin
Chief Financial Officer
profile →
Xenon Pharmaceuticals Inc.
XENE · Healthcare · 12 filings in 24 months
ticker →
Sherry Aulin sold $771K of Xenon Pharmaceuticals (XENE)
Executed Dec 18 2024, disclosed Dec 19 2024, 1 day later.
Value, as filed
$771K
18,709 sh across 2 lots
Executed
Dec 18 2024
the trade date, as filed
Disclosed
Dec 19 2024
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SASherry Aulin (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Xenon Pharmaceuticals Inc. (XENE). The largest single filing was $771K of XENE (18,709 sh across 2 lots, as filed), executed Dec 18 2024.
The name
XENEHealthcare · Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therap…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→